期刊文献+

3种方法提取的B群脑膜炎奈瑟菌外膜囊泡组分的免疫原性、毒性及杀菌活性 被引量:3

Immunogenicity and Toxicity of Outer Membrane Vesicle of Serogroup B Neisseria meningitides Extracted by Three Methods
原文传递
导出
摘要 目的采用3种方法提取B群脑膜炎奈瑟菌(Serogroup B Neisseria meningitidis,MenB)的外膜囊泡(Outer mem-brane vesicle,OMV),并分析其免疫原性、毒性和杀菌活性。方法分别采用去污剂+EDTA、EDTA、从培养上清液中离心提取3种方法获得MenB的OMV,即dOMV、nOMV和sOMV,SDS-PAGE分析OMV主要蛋白组分,Lowry法测定蛋白浓度,LAL试验测定内毒素含量。将3种OMV免疫小鼠,采用ELISA法测定小鼠血清中IgG抗体滴度,杀菌力试验测定3种OMV诱导针对MenB补体依赖的杀菌反应。结果 dOMV、nOMV和sOMV的主要蛋白成分基本一致,内毒素含量分别为5.0×103、7.5×104和4.0×106 EU/mg,产率分别为11.640、10.210和4.135μg/1010个细菌;dOMV、nOMV和sOMV组小鼠血清抗体滴度分为3.98×106、2.51×107和5.62×104,与阴性对照组相比,差异均有统计学意义(P<0.05),杀菌抗体滴度分别为501.70、697.11和55.39。结论用3种不同的方法成功制备了3种MenB的OMV,并对其免疫原性、毒性和杀菌活性进行了比较,为研发B群脑膜炎OMV疫苗提供了理论依据。 Objective To extract the outer membrane vesicle(OMV) of serogroup B Neisseria meningitides(MenB),and analyze its immunogenicity,toxicity and bactericidal activity.Methods The OMV of MenB was extracted by detergent + EDTA,EDTA and centrifugation methods,and named as dOMV,nOMV and sOMV,respectively.The OMVs were analyzed for main protein component by SDS-PAGE,for protein concentration by Lowry method,and for endotoxin content by LAL test.Mice were immunized with the OMVs,then determined for IgG titer in sera by ELISA,and for complement dependent bactericidal response by bactericidal test.Results The main protein components of dOMV,nOMV and sOMV were basically identical,while the endotoxin contents were 5.0 × 103,7.5 × 104 and 4.0 × 106 EU / mg,the outputs were 11.640,10.210 and 4.135 μg / 1010 bacteria,respectively.The serum antibody titers of mice induced by dOMV,nOMV and sOMV were 3.98 × 106,2.51 × 107 and 5.62 × 104,which showed significant difference with those in negative control group(P 0.05),while the bactericidal antibody titers were 501.70,697.11 and 55.39,respectively.Conclusion The OMV of MenB was successfully prepared by three methods and evaluated for immunogenicity,toxicity and bactericidal activity,which provided a theoretical basis for development of OMV vaccine against MenB.
出处 《中国生物制品学杂志》 CAS CSCD 2011年第10期1183-1186,共4页 Chinese Journal of Biologicals
基金 云南省自然科学基金资助项目(2009ZC168M)
关键词 奈瑟球菌 脑膜炎 血清B群 外膜囊泡 疫苗 Neisseria meningitides serogroup B Outer membrane vesicle(OMV) Vaccine
  • 相关文献

参考文献9

  • 1刘汉平,薛红刚,方志正.A群脑膜炎球菌多糖-重组蛋白Pep10结合物的制备及其免疫原性[J].中国生物制品学杂志,2008,21(7):591-594. 被引量:5
  • 2刘方蕾,吴兵,王晶,袁菲,赵志强,杨明,谢贵林.A群奈瑟脑膜炎球菌荚膜多糖-破伤风类毒素结合物的制备及其工艺稳定性[J].中国生物制品学杂志,2010,23(12):1338-1342. 被引量:3
  • 3Fisseha M, Chen P, Brandt B, et al. Characterization of native outer men,brahe vesicles from lpxL mutant strains of Neisseria meaingitidis for use in parenteral vaccination [J]. Infect Immun, 2005, 73 (7) : 4070-4080.
  • 4Baart GJ, Willemsen M, Khatami E, et al. Modeling Neisseria meningitidis B metabolism at different specific growth rates [J]. Biotechnol Bioeng, 2008, 101 (5) : 1022-1035.
  • 5Saunders NB, Shoemaker DR, Brandt BL, et al. Immunogenicity of intranasally administered meningoeoccal native outer membrane vesicles in mice [J ]. Infect Immun, 1999, 67 (1): 113-119.
  • 6Weynants V, Denoel P, Devos N, et al. Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response [J]. Infect Immun,2009, 77 (5) : 2084-2093.
  • 7Van De Waterbeemd B, Streefland M, Van Der Ley P, et al. Im- proved OMV vaccine against Neisseria meningitidis using geneti- cally engineered strains and a detergent-free purification process [J]. Vaccine, 2010, 28 (30): 4810-4816.
  • 8陈柳,李健峰,徐维明,戴宗祥,李智华,孙强明.脑膜炎奈瑟氏菌外膜蛋白NhhA的克隆表达及免疫学分析[J].中国生物工程杂志,2010,30(4):8-12. 被引量:4
  • 9Koeberling O, Giuntini S, Seubert A, et al. Meningocoecal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2 [J]. Clin Vaccine lmmunol, 2009, 16 (2): 156-162.

二级参考文献36

  • 1刘方蕾,吴兵,杜琳,杨淼,王志军,杨福军,罗广.A群奈瑟氏脑膜炎球菌荚膜多糖-破伤风类毒素结合疫苗的制备及其免疫原性研究[J].微生物学免疫学进展,2005,33(2):14-20. 被引量:8
  • 2Ashton F E, Ryan J A, Jones C, et al. Serotype of Neisseria meningitidis associated with an increased incidence of meningitis cases in the Hamilton area. Can J Microbiol, 1983, 29: 129- 130.
  • 3Henderson I R, Nataro J P. Virulence functions of autotransporter proteins. Infect Immun, 2001,69:1231-1243.
  • 4Scarselli M, Rappuoli R, Scarlato V. A common conserved amino acid motif module shared by bacterial and intercellular adhesins : bacterial adherence mimicking cell-cell recognition? Microbiology, 2001,147:250-252.
  • 5Peak I R A, Srikhanta Y, Dieckelmann M, et al. Identification and characterisation of a novel conserved outer membrane protein from Neisseria meningitidis. FEMS Immunol Med Microbiol, 2000, 28:329-334.
  • 6Pizza M, Scarlato V, Masignani V, et al. Identification of vaccine candidates against serogrou PB meningococcus by whole-genome sequencing. Science, 2000,287 : 1816-1820.
  • 7Scarselli M, Serruto D, Montanari P,et al. Neisseria meningitidis NhhA is a multifunctional trimeric autotransporter adhesin. Mol Microbiol, 2006, 61:631-644.
  • 8Sjolinder H, Eriksson J, Maudsdotter L. Meningococcal outer membrane protein NhhA is essential for colonization and disease by preventing phagocytosis and complement attack. Infection and Immunity. 2008, 76( 11 ): 5412-5420.
  • 9Frasch C E, Chapman S. Classification of Neisseria meningitides group B into distinct serotypes I. serologica typing by a microbactericidal method. Infect Immun, 1972, 5 ( 1 ) : 98-102.
  • 10Gold R, Lepow M L, Goldschneider I, et al. Immune response of human infants of polysaccharide vaccines of grou PA and C Neisseria meningitides. J Infect Dis,1977, 136 ( su PPI) : S31- 35.

共引文献9

同被引文献15

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部